NEW YORK (GenomeWeb) – Canon BioMedical said today that it has signed a distribution deal in Benelux for its Novalelle genotyping assays.

Under the agreement, Sanbio, a Netherlands-based distributor that serves the Belgium, the Netherlands, and Luxembourg, will distribute Canon BioMedical's entire portfolio of Novallele assays, controls, and reagents in the region.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: paternal age associated with de novo mutations in children, and more.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.